Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Terminated 6 Withdrawn 3 Recruiting 1

Sponsor Class

OTHER 34 INDUSTRY 7 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 15 Neoplasms 12 Multiple Myeloma 11 Carcinoma, Non-Small-Cell Lung 11 Melanoma 9 Pancreatic Neoplasms 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma 6 Colorectal Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Sarcoma 4 Ovarian Neoplasms 4 Osteosarcoma 4 Hematologic Neoplasms 4 Brain Neoplasms 4 Teratoma 3 Smoldering Multiple Myeloma 3 Small Cell Lung Carcinoma 3 Recurrence 3 Neoplasms, Germ Cell and Embryonal 3 Neoplasm Metastasis 3 Malignant Solid Neoplasm 3 HIV Infections 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3

Interventions

mogamulizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × Lymphoma, T-Cell, Cutaneous × Clear all

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡